An Open Phase 1 Study To Assess The Bioavailibility Of A 250mg Single Dose Of ZD1839 In Patients With Solid Tumours.

  • Johnson, Philip (Principal Investigator)

Project Details

Short titleAn Open Phase 1 Study To Assess The Bioavailibility Of A 250mg Single Dose Of ZD1839 In Patients With Solid Tumours.
StatusFinished
Effective start/end date1/03/0131/12/03

Funding

  • ASTRA ZENECA UK LIMITED